A new trading day began on Monday, with Mind Medicine Inc (NASDAQ: MNMD) stock price down -9.67% from the previous day of trading, before settling in for the closing price of $6.72. MNMD’s price has ranged from $5.03 to $12.22 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 41.32%. With a float of $27.41 million, this company’s outstanding shares have now reached $81.59 million.
In an organization with 57 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 72.78%, operating margin of -1935.9%, and the pretax margin is -2021.54%.
Mind Medicine Inc (MNMD) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mind Medicine Inc is 2.67%, while institutional ownership is 146.46%. The most recent insider transaction that took place on Dec 26 ’24, was worth 141,958. In this transaction Chief Executive Officer of this company sold 19,106 shares at a rate of $7.43, taking the stock ownership to the 526,666 shares. Before that another transaction happened on Dec 26 ’24, when Company’s Chief Accounting Officer sold 2,273 for $7.43, making the entire transaction worth $16,888. This insider now owns 97,270 shares in total.
Mind Medicine Inc (MNMD) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.93% during the next five years compared to 2.29% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Here are Mind Medicine Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.09, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Let’s dig in a bit further. During the last 5-days, its volume was 1.64 million. That was inferior than the volume of 2.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 3.49%. Additionally, its Average True Range was 0.76.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 19.19%, which indicates a significant increase from 0.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.69% in the past 14 days, which was higher than the 91.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.43, while its 200-day Moving Average is $7.20. However, in the short run, Mind Medicine Inc’s stock first resistance to watch stands at $6.63. Second resistance stands at $7.19. The third major resistance level sits at $7.49. If the price goes on to break the first support level at $5.77, it is likely to go to the next support level at $5.47. Assuming the price breaks the second support level, the third support level stands at $4.91.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
With a market capitalization of 445.12 million, the company has a total of 73,332K Shares Outstanding. Currently, annual sales are 0 K while annual income is -95,730 K. The company’s previous quarter sales were 0 K while its latest quarter income was -13,680 K.
